AdvaMed is saddened to share that a beloved member of the AdvaMed family, Wendy Siminski, Senior Vice President of Conferences and Events, has passed away after a brave battle with breast cancer.

March 7, 2022 — AdvaMed is saddened to share that a beloved member of the AdvaMed family, Wendy Siminski, Senior Vice President of Conferences and Events, has passed away after a brave battle with breast cancer. President and CEO Scott Whitaker released the following tribute:

“Wendy embodied the very best of AdvaMed, and her optimistic, ambitious spirit inspired everyone around her to rise to meet her unwavering standard of excellence. You’d never catch Wendy without a big smile and a list of ideas to leave a project better than she found it. The MedTech Conference is successful today because of Wendy’s hard work and determination. 

“Wendy was confident, collaborative, and courageous until the very end. She was a bright light on our team, and that light will continue to guide us and give us warmth in the months and years to come. At AdvaMed, the patients we serve motivate us; Wendy is no exception, and, in fact, she’s the perfect example. Her fight with cancer drives us all to fight harder for medtech innovation, so perhaps future generations – even Wendy’s own daughters – can conquer this terrible disease once and for all.

“We will miss Wendy dearly, and we’re sending comfort, peace, and strength to her family during this difficult time.”

As Senior Vice President, Wendy served as a lead planner for The MedTech Conference, AdvaMed’s annual flagship conference for the medical technology industry, and all other AdvaMed events and conferences. Her efforts grew the Conference’s programming footprint – at the 2020 conference alone, participants could access more than 150 sessions featuring more than 500 speakers – as well as the conference’s standards for inclusion and diversity – at the 2020 conference, women and minorities were represented in 95% of session panels. Prior to her time at AdvaMed, Wendy led teams at BIO, the AUVSI Foundation, O’Keefe Communications, National Trade Productions, and the Cellular Telecommunications and Internet Association.

Wendy was also a fierce patient advocate for the medtech industry; you can read her profile in AdvaMed’s Story of MedTech series here.

She is survived by her two daughters, Kira and Ashley.

In lieu of flowers, Wendy’s family requests that donations be made in Wendy’s honor to METAvivor. One-hundred percent of all donations made to METAvivor go directly to fund grant awards for metastatic breast cancer research.

For more information: www.advamed.org


Related Content

News | Women's Health

March 4, 2026 — QT Imaging Holdings recently announced that Mary W. Yamashita, MD will serve as medical advisor to the ...

Time March 06, 2026
arrow
News | Artificial Intelligence

March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be ...

Time March 03, 2026
arrow
News | Women's Health

Feb.23, 2026 — The first clinical patient received a Clairity Breast cancer risk score, marking a historic milestone in ...

Time February 23, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
News | Remanufactured Refurbished Equipment

Jan. 11, 2026 — The Global Refurbished Medical Imaging Equipment Market Size is projected to grow at a CAGR of 15.07% ...

Time January 23, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — VizMark has received U.S. Food and Drug Administration FDA 510k clearance for VM1, a non-metal visual ...

Time January 19, 2026
arrow
News | Women's Health

Dec. 12. 2025 — A new study has found that an individualized approach to breast cancer screening that assesses patients’ ...

Time December 17, 2025
arrow
News | Breast Imaging

Dec. 16, 2025 — Hologic, Inc, a medical technology company dedicated to improving women’s health, recently announced new ...

Time December 16, 2025
arrow
News | FDA

Dec. 8, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, has submitted a 510(k) premarket ...

Time December 08, 2025
arrow
Subscribe Now